Changes

'''James Gannon''' is Strategic Advisor on Emerging Technology Governance for Novartis AG, a global healthcare and pharmaceutical company. Involved in [[ICANN]] for a number of years focused on security and governance activities, he has served on the [[Customer Standing Committee]], the second [[SSR RT|Security, Stability, and Resilience Review Team]] and as a member of the [[GNSO#GNSO Council|GNSO Council]].  

'''James Gannon''' is Strategic Advisor on Emerging Technology Governance for Novartis AG, a global healthcare and pharmaceutical company. Involved in [[ICANN]] for a number of years focused on security and governance activities, he has served on the [[Customer Standing Committee]], the second [[SSR RT|Security, Stability, and Resilience Review Team]] and as a member of the [[GNSO#GNSO Council|GNSO Council]].  

He was highly involved in the [[IANA]] transition in both the CWG and [[Working Group#CCWG|CCWG]] workstreams. He is currently a member of the [[PTI]] Board of Directors, appointed for a 3-year term by the 2020 [[Nominating Committee]].

He was highly involved in the [[IANA]] transition in both the CWG and [[Working Group#CCWG|CCWG]] workstreams.  

 

He is currently a member of the [[PTI]] Board of Directors, appointed for a 3-year term by the 2020 [[Nominating Committee]], additionally he elected as Chair of PTI's Board Audit Committee in March 2021.

His background includes time as a Chief Information Security Officer for a Digital Health firm in Washington, D.C. and a Security Consultant in Washington, D.C. and Basel, Switzerland.

His background includes time as a Chief Information Security Officer for a Digital Health firm in Washington, D.C. and a Security Consultant in Washington, D.C. and Basel, Switzerland.